Cardiosense lands $15M for AI to predict worsening heart disease from wearables
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance AI Platform for Heart Disease
Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?
Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure
TMCx has progressed virtually in 2020 including Bootcamp, an intensive diligence and relationship building period designed to initiate…
